Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
Article
Drug Trends: Retail and Mail Order Insights
Download Our Drug Trends Infographi
Workers' Comp
Article
Uncertainty clouds the outlook for some workers this fall: home or office?
Late summer typically brings back-to-school rituals for millions of students every year, as well as the close of the vacation season for families a
Mitchell
News Release
Mitchell Teams with Inspektlabs to Offer New Option for AI-Generated Vehicle Appraisals
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Disability
Podcast
Understanding ADA guidance for long COVID disability
Recently, the Biden administration issued guidance on how long-term ef
Workers' Comp
Article
A virtual silver lining: the pandemic’s boost to telemedicine
While some of the pandemic-induced restrictions on everyday life will eventually recede along with the virus, some changes are likely to linger.
Workers' Comp
Article
Leveraging Direction of Care in Workers' Comp to Address Drug Pricing
Direction of care can have a profound influence on reducing the impacts of high drug prices in workers' compensation.